{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:09:09Z","timestamp":1791216549253,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2007,9,6]],"date-time":"2007-09-06T00:00:00Z","timestamp":1189036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,9,6]],"date-time":"2007-09-06T00:00:00Z","timestamp":1189036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1007\/s11060-007-9467-3","type":"journal-article","created":{"date-parts":[[2007,9,5]],"date-time":"2007-09-05T08:19:43Z","timestamp":1188980383000},"page":"165-172","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":155,"title":["Immunonanoshells for targeted photothermal ablation in medulloblastoma and glioma: an in\u00a0vitro evaluation using human cell lines"],"prefix":"10.1007","volume":"86","author":[{"given":"Ronald J.","family":"Bernardi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda R.","family":"Lowery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick A.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Blaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,9,6]]},"reference":[{"key":"9467_CR1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s10439-005-9001-8","volume":"34","author":"LR Hirsch","year":"2006","unstructured":"Hirsch LR, Gobin AM, Lowery AR, Tam F, Drezek RA, Halas NJ, West JL (2006) Metal nanoshells. Ann Biomed Eng 34:15\u201322","journal-title":"Ann Biomed Eng"},{"key":"9467_CR2","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/86684","volume":"19","author":"R Weissleder","year":"2001","unstructured":"Weissleder R (2001) A clearer vision for in\u00a0vivo imaging. Nat Biotechnol 19:316\u2013317","journal-title":"Nat Biotechnol"},{"key":"9467_CR3","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1093\/jnci\/94.23.1740","volume":"94","author":"G McBride","year":"2002","unstructured":"McBride G (2002) Studies expand potential uses of photodynamic therapy. J Natl Cancer Inst 94:1740\u20131742","journal-title":"J Natl Cancer Inst"},{"key":"9467_CR4","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1002\/lsm.20338","volume":"38","author":"PJ Muller","year":"2006","unstructured":"Muller PJ, Wilson BC (2006) Photodynamic therapy of brain tumors-a work in progress. Lasers Surg Med 38:384\u2013389","journal-title":"Lasers Surg Med"},{"key":"9467_CR5","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1177\/153303460300200404","volume":"2","author":"MS Eljamel","year":"2003","unstructured":"Eljamel MS (2003) New light on the brain: the role of photosensitizing agents and laser light in the management of invasive intracranial tumors. Technol Cancer Res Treat 2:303\u2013309","journal-title":"Technol Cancer Res Treat"},{"key":"9467_CR6","doi-asserted-by":"publisher","first-page":"13549","DOI":"10.1073\/pnas.2232479100","volume":"100","author":"LR Hirsch","year":"2003","unstructured":"Hirsch LR, Stafford RJ, Bankson JA, Sershen SR, Rivera B, Price RE, Hazle JD, Halas NJ, West JL (2003) Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc Natl Acad Sci USA 100:13549\u201313554","journal-title":"Proc Natl Acad Sci USA"},{"key":"9467_CR7","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S1567-5769(02)00271-0","volume":"3","author":"H Maeda","year":"2003","unstructured":"Maeda H, Fang J, Inutsuka T, Kitamoto Y (2003) Vascular permeability enhancement in solid tumor: various factors, mechanisms involved and its implications. Int Immunopharmacol 3:319\u2013328","journal-title":"Int Immunopharmacol"},{"key":"9467_CR8","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.canlet.2004.02.004","volume":"209","author":"DP O\u2019Neal","year":"2004","unstructured":"O\u2019Neal DP, Hirsch LR, Halas NJ, Payne JD, West JL (2004) Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles. Cancer Lett 209:171\u2013176","journal-title":"Cancer Lett"},{"key":"9467_CR9","doi-asserted-by":"publisher","first-page":"149","DOI":"10.2147\/nano.2006.1.2.149","volume":"1","author":"AR Lowery","year":"2006","unstructured":"Lowery AR, Gobin AM, Day ES, Halas NJ, West JL (2006) Immunonanoshells for targeted photothermal ablation of tumor cells. Int J Nanomedicine 1:149\u2013154","journal-title":"Int J Nanomedicine"},{"key":"9467_CR10","first-page":"140","volume":"63","author":"R Hernan","year":"2003","unstructured":"Hernan R, Fasheh R, Calabrese C, Frank AJ, Maclean KH, Allard D, Barraclough R, Gilbertson RJ (2003) ERBB2 up-regulates S100A4 and several other prometastatic genes in medulloblastoma. Cancer Res 63:140\u2013148","journal-title":"Cancer Res"},{"key":"9467_CR11","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1054\/bjoc.2001.1987","volume":"85","author":"R Gilbertson","year":"2001","unstructured":"Gilbertson R, Wickramasinghe C, Hernan R, Balaji V, Hunt D, Jones-Wallace D, Crolla J, Perry R, Lunec J, Pearson A, Ellison D (2001) Clinical and molecular stratification of disease risk in medulloblastoma. Br J Cancer 85:705\u2013712","journal-title":"Br J Cancer"},{"key":"9467_CR12","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1200\/JCO.2004.06.032","volume":"22","author":"A Gajjar","year":"2004","unstructured":"Gajjar A, Hernan R, Kocak M, Fuller C, Lee Y, McKinnon PJ, Wallace D, Lau C, Chintagumpala M, Ashley DM, Kellie SJ, Kun L, Gilbertson RJ (2004) Clinical, histopathologic, and molecular markers of prognosis: toward a new disease risk stratification system for medulloblastoma. J Clin Oncol 22:984\u2013993","journal-title":"J Clin Oncol"},{"key":"9467_CR13","doi-asserted-by":"publisher","first-page":"7613","DOI":"10.1158\/1078-0432.CCR-04-0499","volume":"10","author":"A Ray","year":"2004","unstructured":"Ray A, Ho M, Ma J, Parkes RK, Mainprize TG, Ueda S, McLaughlin J, Bouffet E, Rutka JT, Hawkins CE (2004) A clinicobiological model predicting survival in medulloblastoma. Clin Cancer Res 10:7613\u20137620","journal-title":"Clin Cancer Res"},{"key":"9467_CR14","first-page":"953","volume":"5","author":"MF Press","year":"1990","unstructured":"Press MF, Cordon-Cardo C, Slamon DJ (1990) Expression of the HER-2\/neu proto-oncogene in normal human adult and fetal tissues. Oncogene 5:953\u2013962","journal-title":"Oncogene"},{"key":"9467_CR15","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1002\/cncr.20470","volume":"101","author":"M Kawakami","year":"2004","unstructured":"Kawakami M, Kawakami K, Takahashi S, Abe M, Puri RK (2004) Analysis of interleukin-13 receptor alpha2 expression in human pediatric brain tumors. Cancer 101:1036\u20131042","journal-title":"Cancer"},{"key":"9467_CR16","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/sj.neo.7900234","volume":"4","author":"A Mintz","year":"2002","unstructured":"Mintz A, Gibo DM, Slagle-Webb B, Christensen ND, Debinski W (2002) IL-13Ralpha2 is a glioma-restricted receptor for interleukin-13. Neoplasia 4:388\u2013399","journal-title":"Neoplasia"},{"key":"9467_CR17","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1177\/153303460600500307","volume":"5","author":"M Kioi","year":"2006","unstructured":"Kioi M, Husain SR, Croteau D, Kunwar S, Puri RK (2006) Convection-enhanced delivery of interleukin-13 receptor-directed cytotoxin for malignant glioma therapy. Technol Cancer Res Treat 5:239\u2013250","journal-title":"Technol Cancer Res Treat"},{"key":"9467_CR18","doi-asserted-by":"publisher","first-page":"5883","DOI":"10.1158\/0008-5472.CAN-06-0363","volume":"66","author":"J Eguchi","year":"2006","unstructured":"Eguchi J, Hatano M, Nishimura F, Zhu X, Dusak JE, Sato H, Pollack IF, Storkus WJ, Okada H (2006) Identification of interleukin-13 receptor alpha2 peptide analogues capable of inducing improved antiglioma CTL responses. Cancer Res 66:5883\u20135891","journal-title":"Cancer Res"},{"key":"9467_CR19","doi-asserted-by":"publisher","first-page":"5508","DOI":"10.1073\/pnas.0601258103","volume":"103","author":"G Zhou","year":"2006","unstructured":"Zhou G, Roizman B (2006) Construction and properties of a herpes simplex virus 1 designed to enter cells solely via the IL-13alpha2 receptor. Proc Natl Acad Sci USA 103:5508\u20135513","journal-title":"Proc Natl Acad Sci USA"},{"key":"9467_CR20","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S0009-2614(98)00277-2","volume":"288","author":"SJ Oldenburg","year":"1998","unstructured":"Oldenburg SJ, Averitt RD, Westcott SL, Halas NJ (1998) Nanoengineering of optical resonances. Chem Phys Lett 288:243\u2013247","journal-title":"Chem Phys Lett"},{"key":"9467_CR21","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/0021-9797(68)90272-5","volume":"26","author":"W Stober","year":"1968","unstructured":"Stober W, Fink A, Bohn E (1968) Controlled growth of monodisperse silica spheres in the micron size range. J Colloid Interface Sci 26:62\u201369","journal-title":"J Colloid Interface Sci"},{"key":"9467_CR22","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1021\/la00033a010","volume":"9","author":"DG Duff","year":"1993","unstructured":"Duff DG, Baiker A, Edwards P (1993) A new hydrosol of gold clusters. 1. Formation and particle size variation. Langmuir 9:2301\u20132309","journal-title":"Langmuir"},{"key":"9467_CR23","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1097\/01.cad.0000231473.00030.1f","volume":"17","author":"S Sathornsumetee","year":"2006","unstructured":"Sathornsumetee S, Rich JN (2006) New approaches to primary brain tumor treatment. Anti-cancer drugs 17:1003\u20131016","journal-title":"Anti-cancer drugs"},{"key":"9467_CR24","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1200\/JCO.2005.04.7522","volume":"24","author":"NA Butowski","year":"2006","unstructured":"Butowski NA, Sneed PK, Chang SM (2006) Diagnosis and treatment of recurrent high-grade astrocytoma. J Clin Oncol 24:1273\u20131280","journal-title":"J Clin Oncol"},{"key":"9467_CR25","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0147-0272(03)00026-6","volume":"27","author":"RK Mulhern","year":"2003","unstructured":"Mulhern RK, Palmer SL (2003) Neurocognitive late effects in pediatric cancer. Curr Probl Cancer 27:177\u2013197","journal-title":"Curr Probl Cancer"},{"key":"9467_CR26","first-page":"44","volume":"102","author":"RI Jakacki","year":"2005","unstructured":"Jakacki RI (2005) Treatment strategies for high-risk medulloblastoma and supratentorial primitive neuroectodermal tumors. Review of the literature. J Neurosurg 102:44\u201352","journal-title":"J Neurosurg"},{"key":"9467_CR27","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1080\/07357900500449702","volume":"24","author":"A Broniscer","year":"2006","unstructured":"Broniscer A (2006) Past, present, and future strategies in the treatment of high-grade glioma in children. Cancer Invest 24:77\u201381","journal-title":"Cancer Invest"},{"key":"9467_CR28","unstructured":"Liu T, Cai J, Gibo DM, Debinski W (2007) A variant of interleukin 13 fused to diphtheria toxin is selectively cytotoxic to glioblastoma multiforme cells. In: 2007 American Association for Cancer Research Annual Meeting Proceedings, April 14\u201318, 2007, Los Angeles, CA. Philadelphia, PA, AACR"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-007-9467-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-007-9467-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-007-9467-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-007-9467-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,15]],"date-time":"2022-05-15T22:17:02Z","timestamp":1652653022000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-007-9467-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9,6]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["9467"],"URL":"https:\/\/doi.org\/10.1007\/s11060-007-9467-3","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9,6]]},"assertion":[{"value":"1 June 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2007","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2007","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}